Trouble is they need to raise 30-40 million usd in the next two...

Trouble is they need to raise 30-40 million usd in the next two years, with no capacity to create revenue.

The loan forced them to play they're hand now it's an obvious short as anyone shorting can just buy back on market during the next raising.

They need to get partnership/distribution rights ASAP, some form of institutional cash influx to prevent huge dilution.

The science still seems good, but what % will current owners own, when c-pulse 2 has completed phase three trials.